These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
13. Reduced monoamine oxidase activity in platelets: a possible genetic marker for vulnerability to schizophrenia. Wyatt RJ; Murphy DL; Belmaker R; Cohen S; Donnelly CH; Pollin W Science; 1973 Mar; 179(4076):916-8. PubMed ID: 4687789 [TBL] [Abstract][Full Text] [Related]
14. Platelet MAO activity in schizophrenia and other psychiatric illnesses. Sullivan J; Stanfield CN; Dackis C Am J Psychiatry; 1977 Oct; 134(10):1098-1103. PubMed ID: 900261 [TBL] [Abstract][Full Text] [Related]
15. Platelet monoamine oxidase and clinical phenomenology of schizophrenia. Baron M; Gruen R; Levitt M; Kane J Psychiatry Res; 1984 Mar; 11(3):205-9. PubMed ID: 6587413 [TBL] [Abstract][Full Text] [Related]